Wafik S. El-Deiry, MD PhD FACPJan 12
Back to clinic today where we are wearing masks throughout the hospital. Opportunity to mention benefits of physical activity for early stage treated colorectal cancer to reduce fatigue and improve QoL based on what was learned at #GI26 @ASCO on Saturday in San Francisco.
Wafik S. El-Deiry, MD PhD FACPJan 10
Great presentation on “Survivorship Issues in Early-Onset Gastrointestinal Cancers” by Shruti Rajesh Patel, MD, Stanford. #GI26
Wafik S. El-Deiry, MD PhD FACPJan 10
Thank you Sydney Towle for sharing your experiences and insights with the @ASCO GI #GI26 community.
Your powerful words are heard and understood.
Wafik S. El-Deiry, MD PhD FACPJan 10
Band playing outside Moscone Center at #GI26
Wafik S. El-Deiry, MD PhD FACPJan 9
Enjoyable meal of kofta, falafel, tahini, lentil soup, and Mountain Dew at Oasis Grill across the street from Moscone Center where #GI26 is taking place.
Wafik S. El-Deiry, MD PhD FACPJan 9
Great to catch up with my colleague Dr. Bob Vonderheide, Director at @PennCancer at #GI26
Wafik S. El-Deiry, MD PhD FACPJan 9

Important presentation at #GI26 highlighting new guidance to test all patients who are planned to receive a fluoropyrimidine to have DPYD variant testing. A long overdue change in practice that makes sense to reduce toxicities including risk of fatal toxicities. Reminder about uridine triacetate rapid reversal agent.

Capecitabine's Black Box Warning:
Practical Considerations for DPD
Deficiency in Treatment Decisions by
Thomas Holden, MD, Stanford University Medical Center

Wafik S. El-Deiry, MD PhD FACPJan 9
Excellent presentation on Resistance to Treatments Targeting the RAS/RAF/MEK Pathways by Sandra Misale, PhD,
Johns Hopkins at #GI26
Genetic and nongenetic mechanisms and reshaping the TME. Different patterns of resistance seen between inhibitors of specific KRAS alleles vs pan-RAS inhibitors. KRAS gene amplification mentioned.
Wafik S. El-Deiry, MD PhD FACPJan 9
Great presentation on Novel Strategies for Targeting BRAF Mutation by
Elena Elez, MD, PhD, Vall d'Hebron Institute of Oncology #GI26
History, SOC, BREAKWATER, insights into combos with IO for BRAF/CMS4 and BRAF degraders.
Wafik S. El-Deiry, MD PhD FACPJan 9
Great to run into @ASCO CEO @CliffordHudis at #GI26 and to discuss progress in building a world-class cancer center #LegorretaCancerCenter at @BrownUniversity